Acute and chronic rhinosinusitis and allergic rhinitis in relation to environment, comorbidity and ethnicity

Hoffmans, Ruth; Hastan, Deniz; Drunen, Kees van; Fokkens, Wytske

doi:10.1186/2045-7022-5-s4-p26

Cited by 14 publications

(16 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…This value is in the same range as studies using nasal endoscopy (1.2-5.7) 12 and percentages found in the Korean National Health and Nutrition Examination Survey (CRS with nasal polyps, 2.6%; CRS without nasal polyps, 5.8%) 26 but greater than those in the earlier version of the Korean National Health and Nutrition Examination Survey (1.2%) found by Kim et al 9 in South Korea. The prevalence of epidemiologically based CRS found in this study (12%) compares well with these studies (both 611%), with our previous studies using the GA 2 LEN questionnaire (14% to 16%), 8,24 and with other existing literature, where it is found to be 5% to 12%, with significant variation between countries. 6,7,10,27 Although the role of allergy in patients with CRS with and without nasal polyps continues to be controversial, AR might be a potentially relevant factor influencing LM scores in the current population.…”

Section: Discussionsupporting

confidence: 90%

See 1 more Smart Citation

Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology

Loos

Lourijsen

Wildeman

et al. 2019

Journal of Allergy and Clinical Immunology

157

103

View full text Add to dashboard Cite

Background: The prevalence of chronic rhinosinusitis (CRS) measured in epidemiologic studies is 5% to 12%. This might be an overestimation because of overlap with other diseases, such as allergic rhinitis. Objective: We aimed to calculate the prevalence of CRS using a combination of epidemiologically based CRS according to the European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS) together with sinonasal opacification on imaging. Methods: Subjects who underwent a computed tomographic or magnetic resonance imaging scan of the head for any nonrhinologic indication were asked to fill in the Global Allergy and Asthma European Network survey containing EPOS symptom criteria. The scans were evaluated according to the Lund-Mackay (LM) scoring system. Epidemiologically based CRS is based on nasal symptoms according to EPOS; clinically based CRS also encompasses endoscopy and/or CT scanning. Results: Eight hundred thirty-four subjects were included. One hundred seven (12.8%) had epidemiologically based CRS according to EPOS. Of these subjects, 50% had an LM score of 0, 26% had an LM score of 1 to 3, and 23% had an LM score of 4 or greater. Twenty-five (3.0%) subjects had clinically based CRS (based on LM score > _4), and 53 (6.4%) subjects had clinically based CRS (based on LM score >0). Allergic rhinitis was reported by 167 (20%) subjects. In subjects who did not report upper airway symptoms, 57% had an LM score of 0, 30% had an LM score of 1 to 3, and 12% had an LM score of 4 or greater. Conclusion: We found a prevalence of 3.0% to 6.4% of clinically based CRS (depending on an LM cutoff point; ie, LM > _ 4 or LM > 0, respectively) in a relatively randomly selected group of subjects.

show abstract

Section: Discussionsupporting

confidence: 90%

“…12,23 The GA 2 LEN questionnaire was previously used in epidemiologic research on the prevalence of allergy, asthma, and upper airway symptoms. 8,24 Subjects were asked for symptoms of CRS, ARS, asthma, and AR in the last 3 months and in the last year. For the full survey, see Table E1.…”

Section: Measurementsmentioning

confidence: 99%

Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology

Loos

Lourijsen

Wildeman

et al. 2019

Journal of Allergy and Clinical Immunology

157

103

View full text Add to dashboard Cite

show abstract

“…Increased risk for ARS was also found in pediatric patients with AR in a nationwide cohort study of Taiwanese children (Table VII‐6). 353 …”

Section: Acute Rhinosinusitis (Ars)mentioning

confidence: 99%

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Orlandi

Kingdom

Smith

et al. 2021

Int Forum Allergy Rhinol

414

423

View full text Add to dashboard Cite

I. Executive Summary Background The 5 years since the publication of the first International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed foundational progress in our understanding and treatment of rhinologic disease. These advances are reflected within the more than 40 new topics covered within the ICAR‐RS‐2021 as well as updates to the original 140 topics. This executive summary consolidates the evidence‐based findings of the document. Methods ICAR‐RS presents over 180 topics in the forms of evidence‐based reviews with recommendations (EBRRs), evidence‐based reviews, and literature reviews. The highest grade structured recommendations of the EBRR sections are summarized in this executive summary. Results ICAR‐RS‐2021 covers 22 topics regarding the medical management of RS, which are grade A/B and are presented in the executive summary. Additionally, 4 topics regarding the surgical management of RS are grade A/B and are presented in the executive summary. Finally, a comprehensive evidence‐based management algorithm is provided. Conclusion This ICAR‐RS‐2021 executive summary provides a compilation of the evidence‐based recommendations for medical and surgical treatment of the most common forms of RS.

show abstract

“…In the last decade studies have been performed using this classification. In a recent Dutch paper using the GA2LEN questionnaire a prevalence of 18% (17-21%) was found for symptoms pointing to post-viral ARS in three different cities in the Netherlands (38) . ABRS is a rare disease with an incidence of 0.5-2% of viral ARS (common cold) (2,39) .…”

Section: Epidemiologymentioning

confidence: 96%

Executive Summary of EPOS 2020 Including Integrated Care Pathways

Fokkens

Lund

Hopkins

et al. 2020

Rhin

286

179

View full text Add to dashboard Cite

The European Position Paper on Rhinosinusitis and Nasal Polyps 2020 is the update of similar evidence based position papers published in 2005 and 2007 and 2012 (1-3). The core objective of the EPOS2020 guideline is to provide revised, up-to-date and clear evidence-based recommendations and integrated care pathways in ARS and CRS. EPOS2020 provides an update on the literature published and studies undertaken in the eight years since the EPOS2012 position paper was published and addresses areas not extensively covered in EPOS2012 such as paediatric CRS and sinus surgery. EPOS2020 also involves new stakeholders, including pharmacists and patients, and addresses new target users who have become more involved in the management and treatment of rhinosinusitis since the publication of the last EPOS document, including pharmacists, nurses, specialised care givers and indeed patients themselves, who employ increasing self-management of their condition using over the counter treatments. The document provides suggestions for future research in this area and offers updated guidance for definitions and outcome measurements in research in different settings. EPOS2020 contains chapters on definitions and classification where we have defined a large number of terms and indicated preferred terms. A new classification of CRS into primary and secondary CRS and further division into localized and diffuse disease, based on anatomic distribution is proposed. There are extensive chapters on epidemiology and predisposing factors, inflammatory mechanisms, (differential) diagnosis of facial pain, allergic rhinitis, genetics, cystic fibrosis, aspirin exacerbated respiratory disease, immunodeficiencies, allergic fungal rhinosinusitis and the relationship between upper and lower airways. The chapters on paediatric acute and chronic rhinosinusitis are totally rewritten. All available evidence

show abstract

Acute and chronic rhinosinusitis and allergic rhinitis in relation to environment, comorbidity and ethnicity

Abstract: This study was conducted to assess the relation between allergic rhinitis (AR), acute rhinosinusitis (ARS) and chronic rhinosinusitis (CRS) and environment, comorbidity and ethnicity.

Cited by 14 publications

References 0 publications

Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology

Prevalence of chronic rhinosinusitis in the general population based on sinus radiology and symptomatology

International consensus statement on allergy and rhinology: rhinosinusitis 2021

Executive Summary of EPOS 2020 Including Integrated Care Pathways

Contact Info

Product

Resources

About